Stemtech announced StemPets, a new product line designed to enhance the lives of people and their pets. Leveraging the company’s innovation within the stem cell and wellness space, the new product line is expected to launch in the second quarter of 2025.
“We are excited to bring the power of stem cell nutrition to pets, offering a breakthrough solution for pet owners who want to improve their animals’ health and wellness,” said John W. Meyer, Stemtech President & COO. “StemPets is a game changer in pet care, and with the exponential growth in the sector, we believe we are uniquely positioned to capture a significant share of this rapidly expanding market. This is an exciting time for investors, as we are poised to capitalize on a booming industry with innovative, science-backed products that will transform pet healthcare.”
As the company prepares for this expansion, it announced the addition of strategic appointments to its leadership team.
Alejandro Carrillo has been promoted to Vice President of Global Operations. Carrillo joined Stemtech ten years ago in the global sales and marketing department and will now lead global operations activities, focusing on manufacturing, inventory and expansion management.
Srilakshmi Vadlapatla has been named Global Accounts Manager and will assume the role of Chief Financial Officer. Vadlapatla brings experience in global markets and multi-national finance and has led international financial operations, strategic planning and capital management. She will now be responsible for all Stemtech finance matters as the company continues to scale globally.
Manuel Ramirez Garcia was named Director of Global Sales & Field Development. Garcia has more than two decades of experience in international sales and has developed and executed revenue growth strategies across North America, Europe and Asia. Garcia will now help drive Stemtech’s global expansion and market penetration.
“We are excited to have Srilakshmi and Manuel join our leadership team along with Alex in his new role,” said John W. Meyer, Stemtech President and COO. “Their combined expertise in finance, global sales, and field operations will be pivotal as we continue to expand Stemtech’s footprint worldwide. With their leadership, we are poised for even greater growth and innovation in the stem cell nutrition industry.”
